1. All Products
  2. ABC 120mg / 3TC 60mg, disp. and break. tab. in 1/4
Public Pricelist

ABC 120mg / 3TC 60mg, disp. and break. tab. in 1/4

https://medicalguidelines.msf.org/en/node/345
https://msf.oodin.sh/cat/product/98470
NST DORAABLA3TD4

Valid Article

Article is intended to be used with children (<12 years) ONLY.
6.4.2.5 - Fixed-dose combinations of antiretroviral medicines
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J05AR02
Anatomical Therapeutic Chemical Classification according to WHOCC
P
The order of this product needs to be justified and is only acceptable under certain conditions.
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)
SC subscriptions: included in supply or field tools
https://msf.oodin.sh/web/image/product.template/589563/image_1920?unique=c119a89

This combination does not exist.

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

ABACAVIR (ABC) / LAMIVUDINE (3TC)

Therapeutic Action

Fixed-dose combination (FDC) of two antiretrovirals, nucleoside reverse transcriptase inhibitors (NRTI)

Indications

HIV infection, in combination with other antiretrovirals

Instructions for use

The ABC 120mg/3TC 60mg dispersible, breakable tablets (scored for 1/2 or 1/4 dosing) are intended for paediatric use.

The dispersible tablet, breakable in 1/4 (DORAABLA3TD4) is intended for neonates aged 0 to 4 weeks who require ART or PNP (Post-Natal Prophylaxis):

  • neonates < 2 weeks old: 1/4 tablet every other day
  • neonates ≥ 2 weeks old: 1/4 tablet every day

Storage

Below 25°C